PAI Holdings LLC — FDA Class II (D-0590-2026)

PAI Holdings LLC is recalling a drug due to non-compliance with USP or OTC monograph standards. This is a voluntary recall. The specific geographic scope and quantity of the affected product have not been disclosed.

• •PAI Holdings LLC is recalling a drug for safety standard violations.
• •The recall is voluntary and classified as Class II.
• •Specific lot numbers and quantities are not disclosed.
• •Consumers should check their medicine cabinets for this product.

Consumers using this drug may be at risk due to safety standard violations. They should check for any affected products in their homes.